Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENAVOgliflozin Outcome Trial in Patients with Severe Aortic Stenosis after TAVR
KCT0008880Phase 4Recruiting
- Sponsor
- Cardiovascular Research Foundation
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enavogliflozin in aortic valve disease (AVD), sponsored by Cardiovascular Research Foundation. Started Dec 2024; status: recruiting.
02
Drugs
enavogliflozin
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on KCT0008880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008880.